Literature DB >> 33509217

Anti-inflammatory potential of Quercetin in COVID-19 treatment.

Ali Saeedi-Boroujeni1,2,3, Mohammad-Reza Mahmoudian-Sani4.   

Abstract

SARS-CoV-2 is a betacoronavirus causing severe inflammatory pneumonia, so that excessive inflammation is considered a risk factor for the disease. According to reports, cytokine storm is strongly responsible for death in such patients. Some of the consequences of severe inflammation and cytokine storms include acute respiratory distress syndrome, acute lung injury, and multiple organ dysfunction syndromes. Phylogenetic findings show more similarity of the SARS-CoV-2 virus with bat coronaviruses, and less with SARS-CoV. Quercetin is a carbohydrate-free flavonoid that is the most abundant flavonoid in vegetables and fruits and has been the most studied to determine the biological effects of flavonoids. Inflammasomes are cytosolic multi-protein complexes assembling in response to cytosolic PAMP and DAMPs, whose function is to generate active forms of cytokines IL-1β and IL-18. Activation or inhibition of the NLRP3 inflammasome is affected by regulators such as TXNIP, SIRT1 and NRF2. Quercetin suppresses the NLRP3 inflammasome by affecting these regulators. Quercetin, as an anti-inflammatory, antioxidant, analgesic and inflammatory compound, is probably a potential treatment for severe inflammation and one of the main life-threatening conditions in patients with COVID-19.

Entities:  

Keywords:  COVID-19; NLRP3 inflammasome; Quercetin; SARS-CoV-2; SIRT1; TXNIP

Year:  2021        PMID: 33509217     DOI: 10.1186/s12950-021-00268-6

Source DB:  PubMed          Journal:  J Inflamm (Lond)        ISSN: 1476-9255            Impact factor:   4.981


  40 in total

Review 1.  Quercetin. Monograph.

Authors:  Gregory S Kelly
Journal:  Altern Med Rev       Date:  2011-06

2.  The embryonic origin of endocrine cells of the gastrointestinal tract.

Authors:  A Andrew; B Kramer; B B Rawdon
Journal:  Gen Comp Endocrinol       Date:  1982-06       Impact factor: 2.822

3.  Endolymphatic-mastoid shunt operation: results of the 24 cases and revision surgery with the silastic sheet.

Authors:  K Gyo; N Yanagihara
Journal:  Auris Nasus Larynx       Date:  1982       Impact factor: 1.863

4.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

5.  Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers.

Authors:  P C Hollman; J H de Vries; S D van Leeuwen; M J Mengelers; M B Katan
Journal:  Am J Clin Nutr       Date:  1995-12       Impact factor: 7.045

Review 6.  The NLRP3 inflammasome: molecular activation and regulation to therapeutics.

Authors:  Karen V Swanson; Meng Deng; Jenny P-Y Ting
Journal:  Nat Rev Immunol       Date:  2019-08       Impact factor: 53.106

7.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

Authors:  Nanshan Chen; Min Zhou; Xuan Dong; Jieming Qu; Fengyun Gong; Yang Han; Yang Qiu; Jingli Wang; Ying Liu; Yuan Wei; Jia'an Xia; Ting Yu; Xinxin Zhang; Li Zhang
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

Review 8.  NLRP3 Inflammasome-A Key Player in Antiviral Responses.

Authors:  Chunyuan Zhao; Wei Zhao
Journal:  Front Immunol       Date:  2020-02-18       Impact factor: 7.561

9.  A new coronavirus associated with human respiratory disease in China.

Authors:  Fan Wu; Su Zhao; Bin Yu; Yan-Mei Chen; Wen Wang; Zhi-Gang Song; Yi Hu; Zhao-Wu Tao; Jun-Hua Tian; Yuan-Yuan Pei; Ming-Li Yuan; Yu-Ling Zhang; Fa-Hui Dai; Yi Liu; Qi-Min Wang; Jiao-Jiao Zheng; Lin Xu; Edward C Holmes; Yong-Zhen Zhang
Journal:  Nature       Date:  2020-02-03       Impact factor: 49.962

Review 10.  Pharmacological Inhibitors of the NLRP3 Inflammasome.

Authors:  Ayesha Zahid; Bofeng Li; Arnaud John Kombe Kombe; Tengchuan Jin; Jinhui Tao
Journal:  Front Immunol       Date:  2019-10-25       Impact factor: 7.561

View more
  32 in total

Review 1.  COVID-19-induced immune thrombocytopenic purpura; Immunopathogenesis and clinical implications.

Authors:  Mohammad Bahadoram; Ali Saeedi-Boroujeni; Mohammad-Reza Mahmoudian-Sani; Helai Hussaini; Shakiba Hassanzadeh
Journal:  Infez Med       Date:  2022-03-01

Review 2.  Senescence: Pathogenic Driver in Chronic Obstructive Pulmonary Disease.

Authors:  Melissa Rivas; Gayatri Gupta; Louis Costanzo; Huma Ahmed; Anne E Wyman; Patrick Geraghty
Journal:  Medicina (Kaunas)       Date:  2022-06-17       Impact factor: 2.948

Review 3.  As a Modulator, Multitasking Roles of SIRT1 in Respiratory Diseases.

Authors:  Yunxin Zhou; Fan Zhang; Junying Ding
Journal:  Immune Netw       Date:  2022-06-20       Impact factor: 5.851

Review 4.  Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS-CoV-2.

Authors:  Abhishek Gour; Diksha Manhas; Swarnendu Bag; Bapi Gorain; Utpal Nandi
Journal:  Phytother Res       Date:  2021-03-30       Impact factor: 6.388

5.  Biologically Active Compounds in Stizolophus balsamita Inflorescences: Isolation, Phytochemical Characterization and Effects on the Skin Biophysical Parameters.

Authors:  Joanna Nawrot; Jaromir Budzianowski; Gerard Nowak; Iwona Micek; Anna Budzianowska; Justyna Gornowicz-Porowska
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

6.  Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis of Early COVID-19 and Treated at Home Within 3 Days or After 3 Days of Symptom Onset with Prescribed and Non-Prescribed Treatments Between November 2020 and August 2021.

Authors:  Serafino Fazio; Paolo Bellavite; Elisabetta Zanolin; Peter A McCullough; Sergio Pandolfi; Flora Affuso
Journal:  Med Sci Monit       Date:  2021-12-30

7.  Guidelines for Reopening a Nation in a SARS-CoV-2 Pandemic: A Path Forward.

Authors:  Terrance L Baker; Jack V Greiner
Journal:  Medicina (Kaunas)       Date:  2021-05-14       Impact factor: 2.430

Review 8.  Traditional Herbal Medicines, Bioactive Metabolites, and Plant Products Against COVID-19: Update on Clinical Trials and Mechanism of Actions.

Authors:  Safaet Alam; Md Moklesur Rahman Sarker; Sadia Afrin; Fahmida Tasnim Richi; Chao Zhao; Jin-Rong Zhou; Isa Naina Mohamed
Journal:  Front Pharmacol       Date:  2021-05-28       Impact factor: 5.810

Review 9.  Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19.

Authors:  Danielle Brain; Alex Plant-Hately; Bethany Heaton; Usman Arshad; Christopher David; Christian Hedrich; Andrew Owen; Neill J Liptrott
Journal:  Adv Drug Deliv Rev       Date:  2021-06-25       Impact factor: 17.873

Review 10.  Quercetin: A Bioactive Compound Imparting Cardiovascular and Neuroprotective Benefits: Scope for Exploring Fresh Produce, Their Wastes, and By-Products.

Authors:  Irshad Ul Haq Bhat; Rajeev Bhat
Journal:  Biology (Basel)       Date:  2021-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.